Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Volt Pharma Associates

    VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    Genesis Research Group logo

    Genesis Research Group

    Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

    View Profile

    Market access, Regulatory affairs, Research and development

    Company Details

    Volt Pharma Associates
    Engesserstrasse 4B, Freiburg, 79114, Germany
    +49 172 6340202
    Contact Volt Pharma Associates
    Website

     Latest Content from PMHub 

    No “White Space” Between Live Meetings; the top 10 benefits of virtual advisory boards

    Videos and Podcasts | November 30, 2023 | Impetus Digital

    Here's another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #9. No More “White Space” Between Live Meetings Clearly, the...

    Building trust with HCPs: 6 takeaways from our industry webinar

    Press Releases | November 30, 2023 | Graphite Digital

    Key takeaways from the perspectives of industry experts across medical, commercial and digital on the issue of trust in pharma and how this impacts HCP engagement.

    Planting the Seeds for Future Women Leaders in Medicine

    Press Releases | November 28, 2023 | Medscape Education

    What are the qualities needed to be a leader in the medical field of oncology?Of course, you must be a good clinician. But you also have to be wise and...

    So, what is happening with specialised commissioning in the NHS?

    Press Releases | November 28, 2023 | Petauri Evidence

    Specialised commissioning continues to be an issue of significance and uncertainty for both the NHS and industry. What do the latest reports of regional push back on the plans for...

    Novel approach of impactful HCP education programme celebrated by PMEA

    Press Releases | November 28, 2023 | EPG Health

    EPG Health wins Excellence in Engagement through Digital Channels award at PMEA 2023

    Unmet Needs and Novel Advances at the 2023 Women’s Health Master Class

    Press Releases | November 27, 2023 | Medscape Education

    On November 8-9, Medscape Education held the 2nd Annual Women’s Health Master Class—Modernizing Women's Health: Elevating Quality Care for Everyday Practice, two days dedicated to bringing the latest advances in...

    The problem with clinical trials (and how virtual insight-gathering can help)

    White Papers and Resources | November 27, 2023 | Impetus Digital

    While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access.

    Innovative Trials at the 2023 Lloyds Bank British Business Excellence Awards

    Press Releases | November 24, 2023 | Innovative Trials

    Innovative Trials achievements recognized at the Lloyds Bank British Business Excellence Awards

    Healthcare in the age of AI: How will artificial intelligence impact future decision-making?

    White Papers and Resources | November 24, 2023 | Inizio

    Authored by: Constanza Salas, Jhon Galindo and Rachel Howard

    Medscape Medical Affairs Celebrate a High Commendation at the PMEAs

    Press Releases | November 23, 2023 | Medscape Medical Affairs

    Last night the Medscape Medical Affairs team gathered in London for the Pharmaceutical Marketing Excellence Awards (PMEAs) where their entries, Transatlantic Exchanges: Artificial Intelligence and Data Science in Oncology and...